CoChat

Randomized Trial of Telephone Outreach to Improve Medication Adherence and Metabolic Control in Adults With Diabetes

Open access
O’Connor, Patrick J., Schmittdiel, Julie A., Pathak, Ram D., Harris, Ronald I., Newton, Katherine M., Ohnsorg, Kris A., Heisler, Michele, Sterrett, Andrew T., Xu, Stanley, Dyer, Wendy T., Raebel, Marsha A., Thomas, Abraham, Schroeder, Emily B., Desai, Jay R., Steiner, John F. · 2014 · Diabetes Care
Cited by 61

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Medication nonadherence is a major obstacle to better control of glucose, blood pressure (BP), and LDL cholesterol in adults with diabetes. Inexpensive effective strategies to increase medication adherence are needed. RESEARCH DESIGN AND METHODS: In a pragmatic randomized trial, we randomly assigned 2,378 adults with diabetes mellitus who had recently been prescribed a new class of medication for treating elevated levels of glycated hemoglobin (A1C) ≥8% (64 mmol/mol), BP ≥140/90 mmHg, or LDL cholesterol ≥100 mg/dL, to receive 1) one scripted telephone call from a diabetes educator or clinical pharmacist to identify and address nonadherence to the new medication or 2) usual care. Hierarchical linear and logistic regression models were used to assess the impact on 1) the first medication fill within 60 days of the prescription; 2) two or more medication fills within 180 days of the prescription; and 3) clinically significant improvement in levels of A1C, BP, or LDL cholesterol. RESULTS: Of the 2,378 subjects, 89.3% in the intervention group and 87.4% in the usual-care group had sufficient data to analyze study outcomes. In intent-to-treat analyses, intervention was not associated with significant improvement in primary adherence, medication persistence, or intermediate outcomes of care. Results were similar across subgroups of patients defined by age, sex, race/ethnicity, and study site, and when limiting the analysis to those who completed the intended intervention. CONCLUSIONS: This low-intensity intervention did not significantly improve medication adherence or control of glucose, BP, or LDL cholesterol. Wide use of this strategy does not appear to be warranted; alternative approaches to identify and improve medication adherence and persistence are needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc14-0596

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 22

  1. O’Connor, 2006, Improving medication adherence: challenges for physicians, payers, and policy makers, Arch Intern Med, 166, 1802, 10.1001/archinte.166.17.1802 · DOI
  2. Karter, 2009, New prescription medication gaps: a comprehensive measure of adherence to new prescriptions, Health Serv Res, 44, 1640, 10.1111/j.1475-6773.2009.00989.x · DOI · Paper page
  3. Raebel, 2012, Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders, J Gen Intern Med, 27, 57, 10.1007/s11606-011-1829-z · DOI
  4. Steiner, 2012, Rethinking adherence, Ann Intern Med, 157, 580, 10.7326/0003-4819-157-8-201210160-00013 · DOI
  5. Osterberg, 2005, Adherence to medication, N Engl J Med, 353, 487, 10.1056/NEJMra050100 · DOI · Paper page
  6. McDonald, 2013, Through the Quality Kaleidoscope: Reflections on the Science and Practice of Improving Health Care Quality. Closing the Quality Gap: Revisiting the State of the Science
  7. Aubert, 1998, Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial, Ann Intern Med, 129, 605, 10.7326/0003-4819-129-8-199810150-00004 · DOI · Paper page
  8. Derose, 2013, Automated outreach to increase primary adherence to cholesterol-lowering medications, JAMA Intern Med, 173, 38, 10.1001/2013.jamainternmed.717 · DOI
  9. Vollmer, 2011, Use of health information technology to improve medication adherence, Am J Manag Care, 17, SP79
  10. Desai, 2012, Diabetes and asthma case identification, validation, and representativeness when using electronic health data to construct registries for comparative effectiveness and epidemiologic research, Med Care, 50, S30, 10.1097/MLR.0b013e318259c011 · DOI
  11. Nichols, 2012, Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project, Prev Chronic Dis, 9, E110
  12. Heisler, 2012, Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial, Circulation, 125, 2863, 10.1161/CIRCULATIONAHA.111.089169 · DOI
  13. Heisler, 2010, Study protocol: the Adherence and Intensification of Medications (AIM) study—a cluster randomized controlled effectiveness study, Trials, 11, 95, 10.1186/1745-6215-11-95 · DOI
  14. Holman, 2008, 10-year follow-up of intensive glucose control in type 2 diabetes, N Engl J Med, 359, 1577, 10.1056/NEJMoa0806470 · DOI · Paper page
  15. Fischer, 2013, Chipping away: improving primary medication adherence, JAMA Intern Med, 173, 44, 10.1001/jamainternmed.2013.1821 · doi:10.1001/jamainternmed.2013.1821
  16. O’Connor, 2011, Impact of electronic health record clinical decision support on diabetes care: a randomized trial, Ann Fam Med, 9, 12, 10.1370/afm.1196 · DOI · Paper page
  17. Colhoun, 2004, Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial, Lancet, 364, 685, 10.1016/S0140-6736(04)16895-5 · DOI · Paper page
  18. Stuart, 2009, Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings, Diabetes Care, 32, 647, 10.2337/dc08-1311 · DOI
  19. Rasmussen, 2007, Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction, JAMA, 297, 177, 10.1001/jama.297.2.177 · DOI · Paper page
  20. Aubert, 2010, Is there a relationship between early statin compliance and a reduction in healthcare utilization, Am J Manag Care, 16, 459
  21. Franklin, 2013, Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence, Med Care, 51, 789, 10.1097/MLR.0b013e3182984c1f · DOI · Paper page
  22. Bryson, 2007, A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp), Med Care, 45, 497, 10.1097/MLR.0b013e3180329368 · DOI

Cited by

See all 61

Metadata

Authors
O’Connor, P. J., Schmittdiel, J. A., Pathak, R. D., Harris, R. I., Newton, K. M., Ohnsorg, K. A., Heisler, M., Sterrett, A. T., Xu, S., Dyer, W. T., Raebel, M. A., Thomas, A., Schroeder, E. B., Desai, J. R., & Steiner, J. F.
Venue
Diabetes Care
Published
2014-11-08
Volume
37
Issue
12
Pages
3317-3324
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W1987153462
Cited by
61
References
7
FWCI
3.75
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.